| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/29/1999 | WO1999020798A1 Methods for detecting contamination in molecular diagnostics using pcr |
| 04/29/1999 | WO1999020796A1 Zoogloeal and hyphomicrobium spp. nucleic acids |
| 04/29/1999 | WO1999020795A1 Methods for determining coat colour genotypes in pigs |
| 04/29/1999 | WO1999020794A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors |
| 04/29/1999 | WO1999020789A1 Analyte assay using particulate labels |
| 04/29/1999 | WO1999020780A1 Positive-negative selection for homologous recombination |
| 04/29/1999 | WO1999020779A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors |
| 04/29/1999 | WO1999020778A1 Gene delivery vectors and their uses |
| 04/29/1999 | WO1999020777A1 Bacterial resistance in grapevine |
| 04/29/1999 | WO1999020776A1 In planta method for the production of transgenic plants |
| 04/29/1999 | WO1999020775A1 Novel seed specific promoters based on plant genes |
| 04/29/1999 | WO1999020774A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 04/29/1999 | WO1999020773A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS |
| 04/29/1999 | WO1999020772A1 Plasmid vectors |
| 04/29/1999 | WO1999020771A2 Multiply-substituted protease variants with altered net charge for use in detergents |
| 04/29/1999 | WO1999020770A2 Multiply-substituted protease variants |
| 04/29/1999 | WO1999020769A2 Multiply-substituted protease variants |
| 04/29/1999 | WO1999020768A1 Methods for producing amylase enzymes |
| 04/29/1999 | WO1999020767A1 Modified vitamin k-dependent polypeptides |
| 04/29/1999 | WO1999020766A2 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 04/29/1999 | WO1999020765A1 MUTEINS OF INTERLEUKIN 4 SHOWING LOW-AFFINITY AND SHORT-TERM INTERACTION WITH THE COMMON η CHAIN |
| 04/29/1999 | WO1999020764A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 04/29/1999 | WO1999020763A1 D-sorbitol dehydrogenase, genes thereof and use of the same |
| 04/29/1999 | WO1999020762A1 Icam-6 materials and methods |
| 04/29/1999 | WO1999020761A2 Compositions and methods for identifying and testing therapeutics against hsv infection |
| 04/29/1999 | WO1999020760A2 Herg family potassium ion channel genes and protein |
| 04/29/1999 | WO1999020759A1 Chemokines with amino-terminal modifications |
| 04/29/1999 | WO1999020758A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | WO1999020757A2 Alpha-7 nicotinic receptor |
| 04/29/1999 | WO1999020756A2 Human toll homologues |
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020753A2 Peptide bond formation using nucleic acid catalysts |
| 04/29/1999 | WO1999020752A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF |
| 04/29/1999 | WO1999020750A1 METHOD FOR SCREENING FULL-LENGTH cDNA CLONES |
| 04/29/1999 | WO1999020749A1 Method to screen phage display libraries with different ligands |
| 04/29/1999 | WO1999020748A1 Anti-uracil monoclonal antibody and hybridoma producing the same |
| 04/29/1999 | WO1999020747A2 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 04/29/1999 | WO1999020746A2 Plant phosphatases |
| 04/29/1999 | WO1999020744A1 METHOD FOR CLONING AND PRODUCING THE Bs1I RESTRICTION ENDONUCLEASE IN $i(E. COLI) |
| 04/29/1999 | WO1999020743A1 Cell lines useful for in vitro assay for identification of carcinogens |
| 04/29/1999 | WO1999020742A2 A packaging cell line producing siv-pseudotyped mlv |
| 04/29/1999 | WO1999020741A1 Methods and materials for the growth of primate-derived primordial stem cells |
| 04/29/1999 | WO1999020740A2 Methods and materials for the growth of primate-derived primordial stem cells |
| 04/29/1999 | WO1999020726A1 Bleaching compositions comprising multiply-substituted protease variants |
| 04/29/1999 | WO1999020723A2 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 04/29/1999 | WO1999020656A1 Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 04/29/1999 | WO1999020654A2 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 04/29/1999 | WO1999020653A1 Low-toxicity human interferon-alpha analog |
| 04/29/1999 | WO1999020652A1 Feline granulocyte colony-stimulating factor |
| 04/29/1999 | WO1999020644A1 Secreted proteins and polynucleotides encoding them |
| 04/29/1999 | WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | WO1999020641A1 New triplex forming oligonucleotides and their use in anti-hbv |
| 04/29/1999 | WO1999020640A2 High surface density covalent immobilization of oligonucleotide monolayers |
| 04/29/1999 | WO1999020311A1 METHODS FOR CANCER IMMUNOTHERAPY USING RETROVIRAL VECTORS EXPRESSING η INTERFERON |
| 04/29/1999 | WO1999020307A1 NOVEL pheS (BETA) |
| 04/29/1999 | WO1999020306A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/29/1999 | WO1999020302A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | WO1999020121A2 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 04/29/1999 | WO1999020108A1 Human papillomavirus vectors for the episomal transduction of host cells and method of making same |
| 04/29/1999 | WO1999007896A3 Detection and confirmation of nucleic acid sequences by use of oligonucleotides comprising a subsequence hybridizing exactly to a known terminal sequence and a subsequence hybridizing to an unidentified sequence |
| 04/29/1999 | WO1999007887A3 A method of removing nucleic acid contamination in amplification reactions |
| 04/29/1999 | WO1999007858A3 High expression modules containing two or more tandem copies of a methioninase encoding sequence |
| 04/29/1999 | WO1999007740A3 Lipocalin homologs |
| 04/29/1999 | WO1999007735A3 Recombinant expression of insulin c-peptide |
| 04/29/1999 | WO1999007211A9 Controlled germination using inducible phytate gene |
| 04/29/1999 | WO1999006551A3 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 04/29/1999 | WO1999006550A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
| 04/29/1999 | WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 04/29/1999 | WO1999006026A9 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1999002690A9 Systemin |
| 04/29/1999 | WO1999001473A3 Anti-bacterial methods and materials |
| 04/29/1999 | WO1999000509A3 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it, and method for weeding plants |
| 04/29/1999 | WO1998059069A3 Method for identifying cancerigenic agents using a mammal with inhibition of the poly(adp-ribose)-polymerase |
| 04/29/1999 | WO1998051780B1 Method for increasing yields or recombinant proteins |
| 04/29/1999 | WO1998049286A9 Directed evolution of enzymes and antibodies |
| 04/29/1999 | WO1998048027A9 Materials and methods for treatment of retinal diseases |
| 04/29/1999 | WO1998046274A3 Cationic polymers for nucleic acid transfection |
| 04/29/1999 | WO1998044134A3 Bacterial plasmids |
| 04/29/1999 | WO1998042296A9 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 04/29/1999 | DE19756864C1 Production of neuronal or glial progenitor cells |
| 04/29/1999 | DE19746874A1 Isolation of nucleic acids |
| 04/29/1999 | CA2719432A1 Analyte assay using particulate labels |
| 04/29/1999 | CA2672500A1 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 04/29/1999 | CA2672492A1 Bleaching compositions comprising multiply-substituted protease variants |
| 04/29/1999 | CA2308702A1 In planta method for the production of transgenic plants |
| 04/29/1999 | CA2308114A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods |
| 04/29/1999 | CA2308008A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors |
| 04/29/1999 | CA2307330A1 Jmy, a co-activator for p300/cbp, nucleic acid encoding jmy and uses thereof |
| 04/29/1999 | CA2307329A1 Novel seed specific promoters based on plant genes |
| 04/29/1999 | CA2307324A1 Methods for producing amylase enzymes |
| 04/29/1999 | CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | CA2307165A1 Plant phosphatases |
| 04/29/1999 | CA2307012A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | CA2306995A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/29/1999 | CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | CA2306799A1 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |